BMJ 1999;318:164-167 ( 16 January )

General Practice

Coeliac disease in primary care: case finding study

Harold Hin, general practitioner, a Graham Bird,  Peter Fisher, consultant physician, b Nick Mahy, consultant histopathologist, b Derek Jewell, consultant gastroenterologist. c

a Hightown Surgery, Banbury OX16 9DB, b Horton Hospital, Banbury OX16 9AL, c Radcliffe Infirmary, Oxford OX2 6HE

Correspondence to: Dr Hin HaroldHin{at}pgec-horton.demon.co.uk

    Abstract
Top
Abstract
Introduction
Method
Results
Discussion
References

Objectives: To provide evidence of underdiagnosis of coeliac disease and to describe the main presenting symptoms of coeliac disease in primary care.
Design: Case finding in a primary care setting by testing for coeliac disease by using the endomysial antibody test.
Setting: Nine surgeries in and around a market town in central England, serving a population of 70 000.
Participants: First 1000 patients screened from October 1996 to October 1997.
Outcome measures: Determination of endomysial antibody titre of patients fulfilling the study criteria, followed by small intestine biopsy of those with positive results.
Results: The 30 patients (out of 1000 samples) with positive results on the endomysial antibody test all had histological confirmation on small intestine biopsy. The commonest mode of presentation (15/30) was anaemia of varying severity. Most patients (25/30) presented with non-gastrointestinal symptoms. Specificity of the endomysial antibody test was 30/30.
Conclusions: Underdiagnosis and misdiagnosis of coeliac disease are common in general practice and often result in protracted and unnecessary morbidity. Serological screening in primary care will uncover a large proportion of patients with this condition and should be made widely available and publicised. Coeliac disease should be considered in patients who have anaemia or are tired all the time, especially when there is a family history of the disease.


Key messages

  • General practitioners currently see many people with undiagnosed coeliac disease

  • The most likely presentation is a combination of microcytic anaemia, past or present, a family history of the disease, and feeling tired all the time

  • Estimations of endomysial antibody and IgA are reliable diagnostic tools

  • The prevalence of coeliac disease in Britain is higher than the accepted figure of 1:1000 population

  • Increased awareness of the extra intestinal manifestations of coeliac disease, coupled with a low threshold for serological testing, will uncover a large portion of undiagnosed coeliac disease



    Introduction
Top
Abstract
Introduction
Method
Results
Discussion
References

Most gastroenterologists recognise that Samuel Gee's description of coeliac disease in 18881 is now an uncommon presentation---but most general practitioners' image of coeliac disease is still of this classic form. Recent advances, driven by serological assays,2 have led to the realisation that clinically overt cases represent only a small proportion of patients with the disorder. In addition to the classic and the atypical forms of coeliac disease, silent and latent forms have been described.3 Underdiagnosis in the community is due to lack of awareness of the heterogeneity of presentation as well as underuse of serological tests, particularly by general practitioners. 4 5

We used endomysial antibody tests in patients attending primary care to detect coeliac disease. From the cases we found, we describe characteristics of patients with possible coeliac disease.

    Method
Top
Abstract
Introduction
Method
Results
Discussion
References

Participants
The study was carried out in the market town of Banbury and the surrounding villages of Cropredy, Bloxham, and Sibford Gower and the town of Brackley. The nine participating surgeries served a population of 70 000. The population characteristics are typical of central England, with a low immigration rate.

From October 1996 to October 1997, 1000 blood samples were sent for serological screening from patients fulfilling the entry criteria for the study. The criteria were irritable bowel syndrome; anaemia (haemoglobin <115 g/l in female patients and <120 g/l in male patients; family history of coeliac disease; malabsorption symptoms or diarrhoea; fatigue or "tired all the time"; thyroid disease or diabetes; weight loss, short stature, or failure to thrive; epilepsy, infertility, arthralgia, or eczema. This list of criteria was derived from a literature search (done through Medline) and takes into consideration the different modes of presentation possible in a general practice setting.

Ethical approval was obtained from the Oxford medical ethics committee. The potential importance of a positive result was explained to all participants by their general practitioners, and patients' verbal consent was obtained.

Laboratory testing
Endomysial antibodies (EMA) were detected with indirect immunofluorescence. Cryostat sections of distal primate oesophagus were used as substrate, and serum diluted 1:5 in phosphate buffered saline was tested. Slides were washed with phosphate buffered saline and then incubated with goat anti-human IgA (Incstar, Wokingham) at predetermined dilution. Positive samples were identified by the characteristic reticulin-like staining pattern surrounding the oesophageal submucosal smooth muscle bundles. Serum titre of IgA (Beckman, Wycombe) was determined to identify cases of IgA deficiency.

Patients with positive results on the endomysial antibody test were referred for biopsy for confirmation. In those with low titres of IgA (<0.3 mg/l), IgG antigliadin antibody was estimated, as endomysial antibody results were considered unreliable in cases of IgA deficiency.

Small intestine biopsy
Biopsy specimens were taken with a Crosby capsule in the conventional way, either without sedation and steered under fluoroscopic control or by introducing the capsule via an endoscope under sedation. In two cases, distal duodenal specimens were taken at upper gastrointestinal endoscopy. All specimens were reviewed by a consultant histopathologist (NM).

    Results
Top
Abstract
Introduction
Method
Results
Discussion
References

The mean age was 49.9 years for the 271 male patients (range 1-84 years) and 45.2 years (range 6 months to 85 years) for the 729 female patients. Of all patients screened, 5.3% were <10 years old and 3.1% were aged 80-90. The male:female ratio was 1:2.7.

A total of 30 patients (8 male patients and 22 female patients) had positive results on endomysial antibody tests. All consented to small intestine biopsies, and in all 30 patients these showed histological features consistent with a diagnosis of coeliac disease. (In comparison, seven cases of coeliac disease had been diagnosed at the local district general hospital in the preceeding 12 month; the resulting fourfold increase in incidence was solely due to active case finding during the study year.)

Table 1 shows the charateristics of the patients with positive results on the endomysial antibody tests and the reason for testing, divided into primary and secondary reasons for screening. Case 4 was unwell for 9 months and saw six specialists privately before the diagnosis was made. Case 14 similarly visited the general practitioner frequently over many years with sometimes bizarre neurological symptoms, a presentation now known to be associated with coeliac disease.6 Most patients (25/30) did not present with intestinal symptoms, and general practitioners would not have suspected coeliac disease. The severity of symptoms did not always correlate with the severity of histological findings (cases 1, 3, and 6). Case 25 had minimal histological changes of increased intraepithelial lymphocytes (confirmed by two histopathologists). She was screened on the basis of a family history of coeliac disease (brother) and bowel cancer (six first degree relatives affected in the last two generations). She was positive for HLA DQB1*0201 and DQA*0501, alleles known to be primarily associated with coeliac disease.7 She fulfils the criteria for the label of potential coeliac---that is, people with positive serology results plus a positive family history with a high intraepithelial lymphocyte count on small intestine biopsy.3


                              
View this table:
[in this window]
[in a new window]
 

Table 1. Characteristics of patients with positive results on endomysial antibody testing

Table 2 shows the breakdown of the major case finding categories. Of the 126 patients tested who had anaemia of varying degrees (usually with microcytosis), 15 patients had a primary presentation and three had a secondary presentation of anaemia, and three others (cases 8, 13, 30) had an incidental finding of anaemia. Thus 21 out of 30 patients had a history of anaemia (see table 1).


                              
View this table:
[in this window]
[in a new window]
 

Table 2. Major case finding categories. Values are numbers of patients with the disease and numbers of patients screened (percentages; 95% confidence intervals)


                              
View this table:
[in this window]
[in a new window]
 

Table 3. Case finding for coeliac disease in general practice of 6000 adults

The second commonest presentation was the patient who is "tired all the time." Of the 329 patients tested, six patients found to have coeliac disease presented primarily with this symptom, and in three this was a secondary symptom (see table 1).

Of the 28 patients tested because of a family history of coeliac disease, six patients (two in whom the family history was a primary reason for screening and four in whom it was secondary) had positive results on endomysial antibody tests.

All 30 patients with positive results on endomysial antibody tests had positive biopsy results, giving a specificity of 100%. Sensitivity cannot be calculated in this study since patients with negative results on endomysial antibody tests did not undergo biopsy. Sensitivity in previous adult studies ranges from 89% to 100% and specificity of the endomysial antibody test ranges from 94% to 100%.8 Until sensitivity and specificity of the endomysial antibody test are firmly established in our locality, jejunal biopsy remains the test for diagnosis.

Four patients, all women, were identified as IgA deficient, and further investigations of these patients is proceeding.

    Discussion
Top
Abstract
Introduction
Method
Results
Discussion
References

This study represents the first case finding study for coeliac disease in a community in the United Kingdom. Testing for endomysial antibody (with measurement of serum IgA) was chosen for the study because it is widely regarded as the best antibody test for coeliac disease. 9 10

Presenting symptoms
Although the study was of case finding rather than whole population screening, not all patients had symptoms---for example, patients with a family history and some with anaemia who reported vague ill health only on direct questioning. Presenting symptoms were more non-specific than in other published series on coeliac disease. 11 12 In our study, of the 225 patients (22.5%) presenting with gastrointestinal symptoms, only five had coeliac disease, all in the malabsorption/diarrhoea category (93 samples). Surprisingly, none of the patients with irritable bowel symptoms (132 samples) had positive results, suggesting that coeliac disease rarely masquerades as the irritable bowel syndrome in general practice, although such a presentation is not unknown.

Our most important finding is the presence of anaemia: of patients who had this presentation, 11% of the female patients tested and 23% of male patients tested had coeliac disease. We recommend that endomysial antibody should be one of the first line investigations for unexplained anaemia in the community.

General practitioners will notice that "tired all the time" is among the main presenting symptoms. In a prospective study of 220 patients presenting to general practitioners with fatigue, three quarters had a history of emotional distress (depression or anxiety).13 However, abnormal results on laboratory tests were found in 19 patients, of whom eight had anaemia, three hypothyroidism, three infections, one glandular fever, and one carcinomatosis. Although psychosocial factors are by far the commonest cause of fatigue, general practitioners ought to be alert to the possibility of coeliac disease, particularly when there is anaemia. Cases 4 and 20 illustrate this potential pitfall---they were labelled as having chronic fatigue syndrome after long periods of feeling tired.

The average age of the adult patients with coeliac disease (excluding one girl aged 1 year) was 44 years; 43% were aged over 45 and 10% were over 60. Diagnostic delay in the older age group has been commented on by Hankey, who made the specific point that almost half of their patients had attended their general practitioners or hospital outpatient clinics for an average of 28 years with unexplained symptoms or blood test abnormalities.12

Case finding
The clinical importance of the data gathered is best illustrated by analysing in detail the subgroup of patients tested in one of the participating practices, where awareness of coeliac disease is relatively high. The practice, which contributed 417 samples (41.7%) to the study, has 8000 patients, of whom 6000 are adults (age >16 years), with a male:female ratio of 1:1. Before the study there were eight known cases of coeliac disease (six adults and two children). Two of the adults presented with irritable bowel syndrome; one presented with anaemia, two with malabsorption, and one with dermatitis herpetiformis.

Table 3 shows the case finding for coeliac disease that might be expected in a general practice of 6000 adult patients if screening was targeted on the specific diagnostic groups of irritable bowel syndrome, tired all the time, and anaemia. Most cases of coeliac disease in our study included anaemia, so we have analysed the data in greater detail. In the study year, of the 971 samples sent to the Horton hospital by the practice for full blood counts, 197 patients were anaemic by our definition. Review of their clinical details showed a range of conditions from rheumatoid arthritis, bleeding tendencies, cancer, and recent surgery, with 56 cases unexplained. Therefore, the incidence of new cases of anaemia during the study period was 3.3% (197/6000), with 0.9% (56/6000) unexplained. Of the 56 eligible for screening, only five entered the study, giving a screening efficiency of 8.9%. However, we also need to consider past anaemia as an entry criterion. An estimated target for screening based on the 30.5% achieved for "tired all the time" would represent 118 estimated target cases (36 (patients known to have had anaemia who were screened)×100/30.5). With 100% screening efficiency, we predict that in a practice with 6000 adult patients, present and past anaemia would generate a further 20.7 cases of coeliac disease.

Overall, 100% screening efficiency would have identified a further 31.6 cases of coeliac disease in patients with anaemia, who were tired all the time, or had irritable bowel syndrome. As the prevalence of malabsorption and positive family history are not calculable with any degree of accuracy, we have not attempted to apply the statistical analysis to these presentations.

The tip of the iceberg?
Prevalence in other countries varies widely, with the highest in Italy and the west of Ireland, both quoted as 1:300. 17 18 As more patients are screened in Britain, the ultimate prevalence may be similar.

The cost implications of increased numbers of patients diagnosed as having coeliac disease, measured in terms of increased workload for gastroenterologists and dietitians, as well as the prescribing costs of gluten free products, need to be balanced against the cost of delayed diagnosis and complications such as osteoporosis, infertility, and malignancy.19 An endomysial antibody test costs around £10 and the cost of biopsy is estimated as £150. We feel that these expenses are justified, given that coeliac disease is not only a treatable disease but also has serious preventable long term complications.

    Acknowledgments

We thank Evelyn Turner, immunology laboratory technician at the Churchill Hospital, Oxford; Lindsey Dray, Jacquie Brooks, and Ian McClelland from the Horton Hospital laboratory; Catherine Wickens and her team of dietitians; Dr Ken Welch for the HLA studies; Dr Richard Lehman from Hightown Surgery for his inspiration and guidance; and all the participating general practitioners. Special thanks to Dr Sheila Gore for the statistical analysis and Jean Glasspool for her invaluable secretarial help.

Contributors: HH designed the study, coordinated the primary care aspect, and wrote the paper. GB helped to design the study, coordinated the EMA assays, collected and interpreted data, wrote the paper, and is guarantor. PF coordinated the secondary care aspect of the study and did most of the biopsies and helped analyse data. NM coordinated histological aspects, interpreted biopsies, and analysed data. DJ helped design the study, performed some biopsies, interpreted data, and helped finalise the draft.

Funding: Nutricia Dietary Care.

Competing interests: The study was sponsored by makers of gluten free diet foods; they paid for the endomysial antibody tests and for HH to spend one session per week for one year to coordinate the study.

    References
Top
Abstract
Introduction
Method
Results
Discussion
References

  1. Gee S. On the coeliac disease. St Bart Hosp Rep 1888; 24: 17-20.
  2. Unsworth DJ, Brown DL. Serological screening suggests that adult coeliac disease is underdiagnosed in the UK and increases the incidence by up to 12%. Gut 1994; 35: 61-64[Abstract/Free Full Text].
  3. Fergusson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease---active, silent, latent, potential. Gut 1993; 34: 150-151[Free Full Text].
  4. Swinson C, Levi AJ. Is coeliac disease underdiagnosed? BMJ 1980; 281: 1258-1260.
  5. Johnson SD,Watson RGP, McMillan SA, McMaster, Evans A. Preliminary results from follow-up of a large scale population survey of antibodies to gliadin, reticulin and endomysium. Acta Paediatr 1996;(suppl 412):61-4.
  6. Hadjivassiliou M, Gibson A, Davies-Jones GAB, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996; 347: 369-371[Medline].
  7. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910-922[Medline].
  8. Unsworth DJ. Serological diagnosis of gluten sensitive enteropathy. J Clin Pathol 1996; 49: 704-707[Free Full Text].
  9. Ferreira M, Lloyd Davies S, Butler M, Scott D, Clark M, Kumar P. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33: 1633-1637[Abstract/Free Full Text].
  10. McMillan SA, Haughton DJ, Biggart JD, Edgar JD, Porter KG, et al. Predictive value for coeliac disease antibodies to gliadin, endomysium and jejumum in patients attending for jejunal biopsy. BMJ 1991; 303: 1163-1165.
  11. Logan RFA, Tucker G, Rifkind EA, Heading EC, Ferguson A. Changes in the clinical features of coeliac disease in adults in Edinburgh and the Lothians 1969-79. BMJ 1983; 286: 95-97.
  12. Hankey GL, Holmes GKT. Coeliac disease in the elderly. Gut 1994; 35: 65-67[Abstract/Free Full Text].
  13. Ridsdale L, Evans A, Jerrett W, Mandalia S, Osler K, Vora H. Patients with fatigue in general practice: a prospective study. BMJ 1996; 307: 103-106.
  14. Thompson WG. Irritable bowel syndrome: prevalence, prognosis and consequences. Can Med Assoc J 1986; 134: 111-113[Medline].
  15. Jerrett WA. Lethargy in general practice. Practitioner 1981; 4: 731-737.
  16. David A, Pelosi A, McDonald E, Stephens D, Ledger D, Rathbone R, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ 1990; 301: 1199-2202.
  17. Catassi C, Ratsch I-M, Fabiani E, Rossini M, Bordicchia F, Candela, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343: 200-203[Medline].
  18. Mylotte M, Egan-Mitchell B, McCarthy CF, McNicholl B. Incidence of coeliac disease in the west of Ireland. BMJ 1973; i: 703-705.
  19. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease---effect of a gluten free diet. Gut 1989; 30: 333-338[Abstract/Free Full Text].

(Accepted 6 October 1998)

© BMJ 1999

Related Articles

Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study
Ilma R Korponay-Szabó, Katalin Szabados, Jánosné Pusztai, Katalin Uhrin, Éva Ludmány, Éva Nemes, Katri Kaukinen, Anikó Kapitány, Lotta Koskinen, Sándor Sipka, Anikó Imre, and Markku Mäki
BMJ 2007 335: 1244-1247. [Abstract] [Full Text] [PDF]

Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool
Andrew D Hopper, Simon S Cross, David P Hurlstone, Mark E McAlindon, Alan J Lobo, Marios Hadjivassiliou, Marion E Sloan, Simon Dixon, and David S Sanders
BMJ 2007 334: 729. [Abstract] [Full Text] [PDF]

Anaemia in blood donors is not being properly investigated
R Harvey, R J Lock, and D J Unsworth
BMJ 1999 318: 1214. [Extract] [Full Text]

Education, teaching, and learning: all good for health
BMJ 1999 318: 0. [Full Text] [PDF]

Coeliac disease is underdiagnosed in primary care
BMJ 1999 318: 0. [Full Text]

This article has been cited by other articles:

  • Korponay-Szabo, I. R, Szabados, K., Pusztai, J., Uhrin, K., Ludmany, E., Nemes, E., Kaukinen, K., Kapitany, A., Koskinen, L., Sipka, S., Imre, A., Maki, M. (2007). Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 335: 1244-1247 [Abstract] [Full text]  
  • McGowan, K. E., Lyon, M. E., Loken, S. D., Butzner, J. D. (2007). Celiac Disease: Are Endomysial Antibody Test Results Being Used Appropriately?. Clin. Chem. 53: 1775-1781 [Abstract] [Full text]  
  • Gregory, K., Halliday, M., Averill, C., Bhala, N., Tselepis, C., Iqbal, T. (2007). Iron deficiency anaemia: further education regarding the British Society of Gastroenterology guidelines is required. Gut 56: 1319-1319 [Full text]  
  • Leeds, J S, Sanders, D S (2007). Is there an association between coeliac disease and irritable bowel syndrome?. Gut 56: 1326-1327 [Full text]  
  • Jones, R. (2007). Coeliac disease in primary care. BMJ 334: 704-705 [Full text]  
  • Hopper, A. D, Cross, S. S, Hurlstone, D. P, McAlindon, M. E, Lobo, A. J, Hadjivassiliou, M., Sloan, M. E, Dixon, S., Sanders, D. S (2007). Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 334: 729-729 [Abstract] [Full text]  
  • (2007). Abstracts. Gut 56: a1-a145 [Full text]  
  • Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full text]  
  • Halfdanarson, T. R., Litzow, M. R., Murray, J. A. (2007). Hematologic manifestations of celiac disease. Blood 109: 412-421 [Abstract] [Full text]  
  • Goddard, C J R, Gillett, H R (2006). Complications of coeliac disease: are all patients at risk?. Postgrad. Med. J. 82: 705-712 [Abstract] [Full text]  
  • van Heel, D A, West, J (2006). Recent advances in coeliac disease. Gut 55: 1037-1046 [Full text]  
  • Sanders, D. S, Hurlstone, D. P, McAlindon, M. E, Hadjivassiliou, M., Cross, S. S, Wild, G., Atkins, C. J (2005). Antibody negative coeliac disease presenting in elderly people--an easily missed diagnosis. BMJ 330: 775-776 [Full text]  
  • Salvatore, S, Finazzi, S, Ghezzi, A, Tosi, A, Barassi, A, Luini, C, Bettini, B, Zibetti, A, Nespoli, L, d'Eril, G V.M. (2004). Multiple sclerosis and celiac disease: is there an increased risk?. Mult Scler 10: 711-712 [Abstract]  
  • Hoffman, R. J., Dhaliwal, G., Gilden, D. J., Saint, S. (2004). Special Cure. NEJM 351: 1997-2002 [Full text]  
  • Baldas, V., Not, T., Tommasini, A., Ansaldi, F., Demarini, S., Sblattero, D., Marzari, R., Torelli, L., Burlina, A., Tiribelli, C., Ventura, A. (2004). Anti-Transglutaminase Antibodies and Age. Clin. Chem. 50: 1856-1860 [Full text]  
  • Yates, J M, Logan, E C M, Stewart, R M (2004). Iron deficiency anaemia in general practice: clinical outcomes over three years and factors influencing diagnostic investigations. Postgrad. Med. J. 80: 405-410 [Abstract] [Full text]  
  • Tommasini, A, Not, T, Kiren, V, Baldas, V, Santon, D, Trevisiol, C, Berti, I, Neri, E, Gerarduzzi, T, Bruno, I, Lenhardt, A, Zamuner, E, Spano, A, Crovella, S, Martellossi, S, Torre, G, Sblattero, D, Marzari, R, Bradbury, A, Tamburlini, G, Ventura, A (2004). Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch. Dis. Child. 89: 512-515 [Abstract] [Full text]  
  • Nicoleau, A., Balzora, J.D., Chowdhury, M., Saw, D., Nussbaum, M., Lorber, D. (2004). Flatulence and carpopedal spasm: more than social embarrassment. QJM 97: 105-106 [Full text]  
  • Fraquelli, M., Colli, A., Colucci, A., Bardella, M. T., Trovato, C., Pometta, R., Pagliarulo, M., Conte, D. (2004). Accuracy of Ultrasonography in Predicting Celiac Disease. Arch Intern Med 164: 169-174 [Abstract] [Full text]  
  • Lebwohl, B., Green, P. H.R., Maki, M., Mustalahti, K., Knip, M., Fasano, A. (2003). Screening for Celiac Disease. NEJM 349: 1673-1674 [Full text]  
  • Fasano, A (2003). European and North American populations should be screened for coeliac disease. Gut 52: 168-169 [Full text]  
  • Kumar, P J (2003). European and North American populations should be screened for coeliac disease. Gut 52: 170-171 [Full text]  
  • Howard, M R, Turnbull, A J, Morley, P, Hollier, P, Webb, R, Clarke, A (2002). A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J. Clin. Pathol. 55: 754-757 [Abstract] [Full text]  
  • Dockerty, J. L., Williamson, L., Wordsworth, B. P. (2002). Endomysial antibodies in psoriatic arthritis patients. Rheumatology (Oxford) 41: 1195-1196 [Full text]  
  • Logan, E C M, Yates, J M, Stewart, R M, Fielding, K, Kendrick, D (2002). Investigation and management of iron deficiency anaemia in general practice: a cluster randomised controlled trial of a simple management prompt. Postgrad. Med. J. 78: 533-537 [Abstract] [Full text]  
  • Colli, A., Colucci, A., Conte, D., Gomollon, F., Tribole, E., Kupper, C., Pietzak, M., Spanier, B. W.M., Dietz, B., Mulder, C. J.J., Farrell, R. J., Kelly, C. P. (2002). Celiac Sprue. NEJM 347: 446-448 [Full text]  
  • Pengiran Tengah, D S N A, Wills, A J, Holmes, G K T (2002). Neurological complications of coeliac disease. Postgrad. Med. J. 78: 393-398 [Abstract] [Full text]  
  • Porpora, M. G., Picarelli, A., Porta, R. P., Di Tola, M., D'Elia, C., Cosmi, E. V. (2002). Celiac Disease as a Cause of Chronic Pelvic Pain, Dysmenorrhea, and Deep Dyspareunia. Obstet Gynecol 99: 937-939 [Abstract] [Full text]  
  • Popat, S, Bevan, S, Braegger, C P, Busch, A, O'Donoghue, D, Falth-Magnusson, K, Godkin, A, Hogberg, L, Holmes, G, Hosie, K B, Howdle, P D, Jenkins, H, Jewell, D, Johnston, S, Kennedy, N P, Kumar, P, Logan, R F A, Love, A H G, Marsh, M N, Mulder, C J, Sjoberg, K, Stenhammar, L, Walker-Smith, J, Houlston, R S (2002). Genome screening of coeliac disease. J. Med. Genet. 39: 328-331 [Full text]  
  • Collin, P., Rasmussen, M., Kyronpalo, S., Laippala, P., Kaukinen, K. (2002). The hunt for coeliac disease in primary care. QJM 95: 75-77 [Abstract] [Full text]  
  • Wong, M, Scally, J, Watson, K, Best, J (2002). Proximal myopathy and bone pain as the presenting features of coeliac disease. Ann Rheum Dis 61: 87-88 [Full text]  
  • Sanders, D S, Hurlstone, D P, Stokes, R O, Rashid, F, Milford-Ward, A, Hadjivassiliou, M, Lobo, A J (2002). Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad. Med. J. 78: 31-33 [Abstract] [Full text]  
  • Skowera, A, Peakman, M, Cleare, A, Davies, E, Deale, A, Wessely, S (2001). High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. J. Clin. Pathol. 54: 335-336 [Full text]  
  • Baldas, V, Tommasini, A, Trevisiol, C, Berti, I, Fasano, A, Sblattero, D, Bradbury, A, Marzari, R, Barillari, G, Ventura, A, Not, T (2000). Development of a novel rapid non-invasive screening test for coeliac disease. Gut 47: 628-631 [Abstract] [Full text]  
  • Bardella, M. T., Minoli, G., Ravizza, D., Radaelli, F., Velio, P., Quatrini, M., Bianchi, P. A., Conte, D. (2000). Increased Prevalence of Celiac Disease in Patients With Dyspepsia. Arch Intern Med 160: 1489-1491 [Abstract] [Full text]  
  • Feighery, C. (1999). Fortnightly review: Coeliac disease. BMJ 319: 236-239 [Full text]  
  • Harvey, R, Lock, R J, Unsworth, D J (1999). Anaemia in blood donors is not being properly investigated. BMJ 318: 1214-1214 [Full text]  

Rapid Responses:

Read all Rapid Responses

Primary care screening for coeliac disease is already well established in Northern Ireland
William Dickey
bmj.com, 21 Jan 1999 [Full text]
Positive predictive value, not specificity
Christopher Payne, et al.
bmj.com, 21 Jan 1999 [Full text]
Elderly patient without antiendomysial antibody
A Bhattacharyya, et al.
bmj.com, 22 Jan 1999 [Full text]
Blood Tests not Necessarily Reliable
Abigail Neuman
bmj.com, 27 Jan 1999 [Full text]
Even minor haematological abnormalities should alert to the possibility of coeliac disease
Michael Mitchell
bmj.com, 9 Feb 1999 [Full text]
Coeliac disease in primary care: case finding study
R Harvey
bmj.com, 16 Feb 1999 [Full text]
Coeliac disease extra intestinal manifestations in paediatric population
Alessandro Ventura
bmj.com, 23 Feb 1999 [Full text]
Screening for Coeliac disease
S Z Abbas
bmj.com, 23 Feb 1999 [Full text]
Not recognized rather than silent
Simon Johnston
bmj.com, 25 Feb 1999 [Full text]
The relevance of age in screening CD
Federico Biagi
bmj.com, 29 Apr 1999 [Full text]

Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview